Week in Washington

Week in Washington is brought to you by Michael Cohen, PhD. Tune in each week to read the latest on healthcare policy and get a glimpse of what’s on the horizon.

Week in Washington

9/29/2022

Part B Premiums and Deductibles Go Down

CMS announced this week that 2023 Medicare Part B premiums and deductibles will be down in 2023. In 2022, Medicare Part B premiums and deductibles had a large increase as a result of the expected costs of Aduhelm, the Alzheimer’s drug. However, once CMS ruled it would not take on the expected costs of the drugs, it became apparent that the Medicare costs were over-estimated. Consequently, CMS announced that:

“The standard monthly premium for Medicare Part B enrollees will be $164.90 for 2023, a decrease of $5.20 from $170.10 in 2022. The annual deductible for all Medicare Part B beneficiaries is $226 in 2023, a decrease of $7 from the annual deductible of $233 in 2022”

Congress

As part of a continuing resolution to fund the government this September, Congress is expected to include a temporary resolution that would extend the Medicare-Dependent and Low-Volume Hospital programs until December 16, as reported by Axios. The change would help stave off a $600 million funding cut to rural hospitals. Congress will deal with a final solution for these programs as well as address sequestration after the midterm elections (i.e., sometime before the December 16th deadline).

New Medicaid Program

Oregon was approved for a Medicaid waiver that would allow the state to keep children continuously enrolled until they turn 6 years old. Given concern that ending the public health emergency may adversely affect this population, other states are expected to follow Oregon’s path

Happy National Coffee Day!

Previous editions: 

09/22/2022: Week in Washington

09/15/2022: Week in Washington

09/08/2022: Week in Washington

09/01/2022: Week in Washington

 

 

08/25/2022: Week in Washington

08/18/2022: Week in Washington

08/04/2022: Week in Washington

07/28/2022: Week in Washington

Read More Wakely Insights
©2017-2022 Wakely Consulting Group LLC  All Rights Reserved. The materials in this document represent the opinion of the authors and are not representative of the views of Wakely Consulting Group. Wakely does not certify the information, nor does it guarantee the accuracy and completeness of such information. Use of this information is voluntary.